Option chain shows key data for UiPath's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for UiPath.

UiPath (NYSE:PATH) Stock, Option Chain

UiPath

UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

Cathie Wood's Monday Moves: $4.8M Spotify Stock Sale Meets $4.7M Pinterest Shopping Spree

Equities

News

Markets

Tech

ETFs

ACCD

ARKF

ARKG

ARKK

CRSP

IBTA

PATH

RBLX

RDDT

Ark Invest made significant trades involving Tempus AI, CRISPR Therapeutics, UiPath, Roblox, Reddit, Accolade, and Ibotta. ARKG and ARKK funds bought shares, while ARKW and ARKF funds sold shares.

Cathie Wood&#39;s Ark Invest Is Betting Big On This AI Darling And No It&#39;s Not Nvidia

BLBD

ZETA


The old adage that stock prices tend to rise early in the year after a slump in the final weeks of the preceding year—the so-called January effect—is not necessarily true in general and certainly not the

Top 3 High-Risk, High-Reward Plays for Bullish Investors

UiPath Inc

Pathfinder Bancorp Inc

PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy Inc

Pathfinder Ventures Inc

PATHFINDER VENTURES INC by PATHFINDER VENTURES INC.

Pathward Financial Inc

On Friday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), CRISPR Therapeutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRSP#NASDAQ">CRSP</a>), UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>), Reddit Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>), Accolade Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>), and Ibotta Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBTA#NYSE">IBTA</a>).
The Tempus AI Trade
Ark Invest&#8217;s Ark Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) and Ark Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) funds made substantial purchases of Tempus AI shares. The ARKG fund acquired 27,188 shares, while the ARKK fund bought a whopping 159,344 shares.
Based on the closing price of $35.15, the total value of these trades is approximately $6.57 million. This move aligns with Ark Invest&#8217;s <a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">recent trend of investing</a> in AI-driven companies.
The CRSP Trade
Ark Invest&#8217;s ARKG and ARKK funds also bought shares of CRISPR Therapeutics. The ARKG fund purchased 21,730 shares, while the ARKK fund added 125,690 shares.
Given the closing price of $40.53, the total value of these trades is approximately $5.96 million.
The PATH, RBLX, and RDDT Trades
On the other hand, Ark Invest sold shares of UiPath, Roblox, and Reddit. The ARKK fund offloaded 199,224 shares of UiPath, and 148,591 shares of Roblox, and the ARKW fund sold 5,215 shares of Reddit.
These sales indicate a shift in Ark Invest&#8217;s portfolio strategy.
Other Key Trades:
<ul>
<li>Ibotta Inc.: Ark Invest&#8217;s Ark Fintech Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>) fund bought 4,364 shares of Ibotta.</li>
<li>Accolade Inc.: The ARKG fund sold 284,775 shares of Accolade.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42966790/cathie-woods-ark-invest-trims-palantir-again-as-peter-thiel-co-founded-firms-stock-tumbles-nearly-15-in-2025">Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In First 2 Weeks Of 2025</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image via Benzinga YouTube and Unsplash

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$135.00</td>
<td>$35.8K</td>
<td>84.7K</td>
<td>106.9K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$237.50</td>
<td>$42.3K</td>
<td>10.2K</td>
<td>26.6K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$425.00</td>
<td>$39.1K</td>
<td>10.1K</td>
<td>12.7K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$400.00</td>
<td>$64.6K</td>
<td>12.7K</td>
<td>11.3K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$32.00</td>
<td>$215.4K</td>
<td>286</td>
<td>2.1K</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$640.00</td>
<td>$1.2 million</td>
<td>749</td>
<td>310</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$240.00</td>
<td>$90.0K</td>
<td>2.0K</td>
<td>276</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$690.00</td>
<td>$394.9K</td>
<td>1</td>
<td>266</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$20.00</td>
<td>$26.5K</td>
<td>1.2K</td>
<td>116</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$180.00</td>
<td>$83.0K</td>
<td>2.0K</td>
<td>112</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option trade that happens to be bullish, expiring in 2 day(s) on January 17, 2025. This event was a transfer of 199 contract(s) at a $135.00 strike. The total cost received by the writing party (or parties) was $35.8K, with a price of $180.0 per contract. There were 84798 open contracts at this strike prior to today, and today 106920 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 225 contract(s) at a $237.50 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $42.3K, with a price of $188.0 per contract. There were 10238 open contracts at this strike prior to today, and today 26613 contract(s) were bought and sold. 
• Regarding MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we observe a call option sweep with bearish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 126 contract(s) at a $425.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $39.1K, with a price of $315.0 per contract. There were 10125 open contracts at this strike prior to today, and today 12793 contract(s) were bought and sold. 
• Regarding MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we observe a call option sweep with bullish sentiment. It expires in 2 day(s) on January 17, 2025. Parties traded 380 contract(s) at a $400.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $64.6K, with a price of $170.0 per contract. There were 12705 open contracts at this strike prior to today, and today 11323 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a call option sweep that happens to be bearish, expiring in 212 day(s) on August 15, 2025. This event was a transfer of 258 contract(s) at a $32.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $215.4K, with a price of $835.0 per contract. There were 286 open contracts at this strike prior to today, and today 2177 contract(s) were bought and sold. 
• For INTU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), we notice a call option trade that happens to be bearish, expiring in 156 day(s) on June 20, 2025. This event was a transfer of 300 contract(s) at a $640.00 strike. The total cost received by the writing party (or parties) was $1.2 million, with a price of $4320.0 per contract. There were 749 open contracts at this strike prior to today, and today 310 contract(s) were bought and sold. 
• For MDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>), we notice a put option trade that happens to be bearish, expiring in 16 day(s) on January 31, 2025. This event was a transfer of 150 contract(s) at a $240.00 strike. The total cost received by the writing party (or parties) was $90.0K, with a price of $600.0 per contract. There were 2089 open contracts at this strike prior to today, and today 276 contract(s) were bought and sold. 
• Regarding ASML (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>), we observe a call option sweep with neutral sentiment. It expires in 121 day(s) on May 16, 2025. Parties traded 43 contract(s) at a $690.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $394.9K, with a price of $9183.0 per contract. There were 1 open contracts at this strike prior to today, and today 266 contract(s) were bought and sold. 
• For PATH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), we notice a call option sweep that happens to be bullish, expiring in 730 day(s) on January 15, 2027. This event was a transfer of 100 contract(s) at a $20.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.5K, with a price of $265.0 per contract. There were 1280 open contracts at this strike prior to today, and today 116 contract(s) were bought and sold. 
• For SNOW (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>), we notice a call option trade that happens to be bearish, expiring in 156 day(s) on June 20, 2025. This event was a transfer of 50 contract(s) at a $180.00 strike. The total cost received by the writing party (or parties) was $83.0K, with a price of $1660.0 per contract. There were 2017 open contracts at this strike prior to today, and today 112 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AAPL

ASML

INTU

MSFT

MSTR

NVDA

SMCI

SNOW

10 Information Technology Stocks Whale Activity In Today's Session

Needham analyst Scott Berg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Hold to Hold.

Reiteration

Analyst Ratings

Needham Reiterates Hold on UiPathto Hold

In the latest quarter, 9 analysts provided ratings for UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for UiPath, revealing an average target of $15.67, a high estimate of $18.00, and a low estimate of $13.00. This current average represents a 2.06% decrease from the previous average price target of $16.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1736532017_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of UiPath by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeff Hickey</td>
<td>UBS</td>
<td>Announces</td>
<td>Sell</td>
<td>$14.00</td>
<td>-</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$16.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to UiPath. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of UiPath compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of UiPath's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of UiPath's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/PATH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on UiPath analyst ratings.</a>
<h2>Get to Know UiPath Better</h2>
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
<h3>UiPath's Financial Performance</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, UiPath showcased positive performance, achieving a revenue growth rate of 8.82% as of 31 October, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: UiPath's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -3.0%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): UiPath's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.6% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.4%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into UiPath Stock: Analyst Perspectives (9 Ratings)

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and lowers the price target from $16 to $15.

Price Target

Barclays Maintains Equal-Weight on UiPath, Lowers Price Target to $15

WIIM

ANET

APLD

ARBB

BLIN

CMBM

CPSH

CRNT

DELL

HIMX

IONQ

LDTC

LIDR

LOGI

MOBBW

OKTA

ORKT

PERF

SHOP

SMSI

VRME

VSAT

VUZI

XTIA

ZENV

Shares of companies within the broader tech sector are trading higher amid market strength and may be in reaction to Microsoft's plan to invest approximately $80 billion into AI data center development in FY25.

U.S. stocks were higher, with the Dow Jones index gaining over 200 points on Monday.
Shares of fuboTV Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) rose sharply during Monday's session after the company announced it entered into a definitive agreement for Disney to combine its Hulu with Fubo to form a <a href="https://www.benzinga.com/25/01/42816545/fubotv-and-disney-near-merger-to-create-second-largest-digital-tv-provider-shares-soar-report">virtual MVPD company.</a>
fuboTV shares jumped 140% to $3.4501 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Serve Robotics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) surged 21.7% to $23.18 after the company announced it raised $86 million in funding for December and $167 million for 2024.</li>
<li>Paycor HCM, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) gained 21.5% to $22.52. Needham analyst Scott Berg reiterated Paycor HCM with a Buy and maintained a $20 price target.</li>
<li>Vuzix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>) surged 21.4% to $5.33.</li>
<li>Amprius Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) rose 19% to $3.9000.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) gained 18.3% to $18.08 after the company revealed plans for 2025 including layoffs of approximately 400 employees and other spending reduction measures.</li>
<li>Ceragon Networks Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNT#NASDAQ">CRNT</a>) rose 16.8% to $5.53.</li>
<li>LanzaTech Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) gained 16% to $1.9500.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) surged 14% to $19.96.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) rose 11% to $36.97.</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) gained 10.5% to $99.29.</li>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares rose 10.5% to $2.9100.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) gained 9% to $4.0124.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares gained 8.8% to $20.71.</li>
<li>Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) rose 8% to $291.92.</li>
<li>Capri Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) rose 7.9% to $21.88 after BMO Capital upgraded the stock from Market Perform to Outperform and raised its price target from $25 to $31.</li>
<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) rose 7.8% to $22.24 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $19 to $27.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) gained 6.9% to $14.19.</li>
<li>Teradyne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TER#NYSE">TER</a>) surged 6.2% to $138.79 after Northland Capital Markets upgraded the stock from Market Perform to Outperform and raised its price target from $117 to $154.</li>
</ul>
Now Read This: 
<ul>
<li><a href="Cramer: 'At This Point,' SoundHound AI Rally 'Is A Short Squeeze'">Cramer: &#8216;At This Point,&#8217; SoundHound AI Rally &#8216;Is A Short Squeeze&#8217;</a></li>
</ul>

AMPX

ASAN

COIN

CPRI

FUBO

LNZA

PLUG

PYCR

QUBT

RGTI

SEDG

SERV

FuboTV, Serve Robotics, SolarEdge Technologies And Other Big Stocks Moving Higher On Monday

ADBE

ADSK

AGYS

APPN

BILL

BTCS

BTDR

BTOG

CDNS

CLSK

CRWD

CWAN

CYBR

DDOG

DOCU

DSGX

ESTC

ETWO

EVCM

EXFY

FICO

FRSH

FTNT

GREE

GRYP

HTCR

HUBS

KVYO

LMFA

LSPD

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

NCTY

NICE

NTNX

PANW

PCOR

PRCH

RAMP

RBRK

SDIG

SNPS

TEAM

TRAK

TZUP

UPLD

Shares of stocks in the broader software sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

UBS analyst Jeff Hickey initiates coverage on UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sell rating and announces Price Target of $14.

Initiation

UBS Initiates Coverage On UiPath with Sell Rating, Announces Price Target of $14

U.S. competitiveness takes center stage in 2025 with four key investment themes—energy independence, defense innovation, infrastructure, and automation—poised to bolster portfolio growth. Global X's 2025 Investment Outlook, led by Scott Helfstein, highlights these transformative trends as critical drivers of resilience <a href="https://www.benzinga.com/topic/us-economy">in the coming year.</a>
<h2 class="wp-block-heading">Infrastructure Gets A Glow-Up</h2>
America&#8217;s infrastructure renaissance is going full throttle, with $700 billion in spending set to energize construction, equipment, and materials companies. This may bode well for investors in the Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>).
These stalwarts of the old economy are reinventing themselves with cutting-edge tech to expand margins—all while trading at attractive valuations compared to the broader S&amp;P 500.
<h2 class="wp-block-heading">The Defense Play: Beyond Jets &amp; Ships</h2>
Global tensions are driving a pivot from traditional defense platforms to high-tech solutions like AI-driven drones and cybersecurity systems. 
Palantir Technologies Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) Artificial Intelligence Platform and International Business Machines Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) WatsonX AI come to mind here.
Defense revenues are expected to jump nearly 10%, with margins climbing from 5.2% to 7.6%. Success will favor those adopting automation and next-generation technologies in this competitive landscape.
Read Also: <a href="https://www.benzinga.com/news/small-cap/24/12/42438879/manufacturing-tariffs-small-cap-could-steal-the-show-in-2025">Manufacturing Comeback? Strategist Expects Tariffs To Help Small-Cap Stocks But Weigh On Consumers</a>
<h2 class="wp-block-heading">Automation &amp; Onshoring: A Tech Revolution</h2>
With the U.S. accelerating its onshoring efforts, automation and AI are emerging as the driving forces powering the shift.
Software companies and data centers are prepping for a revenue surge, with mega-cap tech upping its spending on data centers to $250 billion in 2025. 
Robotics and IoT hardware could also rebound from a sales plateau, making the automation sector one to watch. Companies enabling robotics and automation such as Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), ABB (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABBNY#OTC">ABBNY</a>), Rockwell Automation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), Zebra Technologies&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>), Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) and UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) come to mind.
<h2 class="wp-block-heading">Energy Independence Goes Nuclear</h2>
Energy's next frontier? Nuclear. With mega-cap tech giants eyeing modular nuclear reactors as a green and reliable power source, demand for uranium is heating up. Beyond the U.S., countries like Japan and Germany are also jumping on the nuclear bandwagon, signaling a global shift toward energy resilience.
U.S. companies such as Constellation Energy&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), Cameco&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) and NuScale Power&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) come to mind.
Helfstein's roadmap suggests a year of targeted strategies. By aligning portfolios with these U.S.-centric themes, investors might not just weather volatility—they could thrive in the chaos.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/24/12/42437267/berkshire-palantir-etfs-add-high-octane-trading-options-with-direxions-launch">Berkshire, Palantir ETFs Add High-Octane Trading Options With Direxion&#8217;s Launch</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Sector ETFs

Trading Ideas

ABBNY

ISRG

PLTR

ZBRA

2025 Investment Themes: AI, Energy, Defense Redefine US Markets

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and raises the price target from $15 to $16.

Barclays Maintains Equal-Weight on UiPath, Raises Price Target to $16

Morgan Stanley analyst Keith Weiss maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and raises the price target from $15 to $16.

Morgan Stanley Maintains Equal-Weight on UiPath, Raises Price Target to $16

UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) analysts stay mostly on the sidelines with concerns for the short-term after the company reported third-quarter financial results Thursday.
The PATH Analysts: Oppenheimer analyst Brian Schwartz maintained a Perform rating on UiPath with no price target.
RBC Capital Markets analyst Matthew Hedberg maintained a Sector Perform rating with a $16 price target.
Truist analyst Terry Tillman maintained a Hold rating with a $14 price target.
KeyBanc Capital Markets analyst Jason Celino maintained a Sector Weight rating with no price target.
JPMorgan analyst Mark Murphy maintained an Overweight rating and raised the price target from $17 to $18.
Oppenheimer on PATH: Management commentary could suggest that stabilization is expected for the company next year, Schwartz said in a new investor note.
The analyst said margin growth returning and guidance for faster free cash flow growth are positives from the quarter. The negatives were soft guidance, modest billings growth and declining net new ARR (annual recurring revenue) trends, the analyst added.
"F3Q results and guidance are unlikely to alleviate investor concerns that AI is weakening the company's moat," Schwartz said.
RBC Capital on PATH: The quarterly results showed improved execution and a stable demand environment Hedberg said in a new investor note.
The analyst highlighted the company's commentary on stabilized net new ARR in the report.
"We continue to believe PATH is likely to remain range-bound over the medium term and as execution improvement plays out and the agent vision unfolds," Hedberg said.
Hedberg highlighted UiPath's commentary on early interest from customers with over 1,000 sign-ups for the Agent Builder product.
"While we like the agent vision and improved execution, we think it will take some time to see tangible benefits from agentic solutions, and we'd like to see more proof points of stability in results."
Truist on PATH: The company's growth remains sluggish going forward, Tillman said in a new investor note.
"The story remains a work in progress in terms of improving annualized renewal run-rate and returning net new ARR to a position of solid growth," Tillman said.
The analyst said the company showed progress in the third quarter with advancing partnerships and early adoption of its agentic automation.
"Sustained execution improvement remain key to growth reacceleration, in our opinion."
KeyBanc on PATH: Initial fiscal 2026 commentary was more mixed than expected, Celino said in a new investor note.
The analyst said the commentary that net new ARR dollars are expected to stabilize could be viewed as a downtick versus consensus estimates of a modest uptick.
"In terms of macro, UiPath noted trends remain largely consistent with no noticeable signs of improvements or deterioration," Celino said.
Celino said there could be long-term opportunities, but the near-term execution and growth challenges remain near-term concerns.
JPMorgan on PATH: The company showed a positive tone with its outlook and commentary, Murphy said in a new investor note.
The analyst said the company's Second Act is centered on the Agentic Model.
"UiPath appears to be making bold moves and speaking very confidently to its Agentic vision, conveying an ability to up-level conversations with customers and elevating its platform beyond just automation," Murphy said.
The new platform could open up the company for "new growth vectors," the analyst said.
"Overall, we view the performance in the quarter as solid, and see the business as mostly stable/stabilizing."
PATH Price Action: UiPath stock is down 2.47% to $14.58 on Friday versus a 52-week trading range of $10.37 to $27.87. The stock is down 39% year-to-date in 2024.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42363278/us-economy-adds-227000-jobs-in-november-wage-growth-accelerates">US Economy Adds 227,000 Jobs In November, Wage Growth Accelerates</a>
Photo: Courtesy of UiPath, Inc.

Earnings

Guidance

Movers

UiPath 'Story Remains A Work In Progress': Analysts Want To See More After Q3 Results, 'Sustained Execution Remains Key'

BMO Capital analyst Keith Bachman maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Market Perform and raises the price target from $15 to $16.

BMO Capital Maintains Market Perform on UiPath, Raises Price Target to $16

RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sector Perform and maintains $16 price target.

RBC Capital Reiterates Sector Perform on UiPath, Maintains $16 Price Target

JP Morgan analyst Mark Murphy maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Overweight and raises the price target from $17 to $18.

JP Morgan Maintains Overweight on UiPath, Raises Price Target to $18

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Friday.
Shares of Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/insights/earnings/24/12/42351795/smith-wesson-brands-q2-earnings-insights">second-quarter results</a>.
The company posted net sales of $129.7 million, an increase of 3.8%, over the year-ago period and 46.8%, over the previous quarter.
Smith &amp; Wesson Brands shares dipped 15.8% to $11.48 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) shares tumbled 81.2%</li>
<li> to $10.50 in pre-market trading after surging 599% on Thursday.</li>
<li>zSpace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) declined 31.7% to $15.01 in pre-market trading after jumping 340% on Thursday.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares tumbled 10.6% to $49.29 in pre-market trading following third-quarter results.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) fell 6.2% to $2.87 in pre-market trading.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) dipped 4.1% to $14.34 in pre-market trading following third-quarter results.</li>
<li>Douglas Dynamics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) fell 4% to $24.31 in pre-market trading.</li>
<li>Movado Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) dropped 3.3% to $20.11 in pre-market trading. The company, on Thursday, reported third-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42357598/dow-dips-more-than-200-points-ahead-of-jobs-report-investor-sentiment-declines-fear-greed-index-remains-in-greed-zone">Dow Takes A Breather After Record Close, Dips Over 200 Points Ahead Of Jobs Report: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

EGHT

ORIS

PLOW

SWBI

ZSPC

Smith & Wesson Brands, Samsara, UiPath And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Analysts' ratings for UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) over the last quarter vary from bullish to bearish, as provided by 2 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated UiPath and provided 12-month price targets. The average target is $15.0, accompanied by a high estimate of $17.00 and a low estimate of $13.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 11.76%. 
<img src="https://www.benzinga.com/files/images/story/2024/1733490188_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of UiPath among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to UiPath. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of UiPath compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of UiPath's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into UiPath's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PATH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on UiPath analyst ratings.</a>
<h2>About UiPath</h2>
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
<h3>Unraveling the Financial Story of UiPath</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: UiPath's remarkable performance in 3 months is evident. As of 31 July, 2024, the company achieved an impressive revenue growth rate of 10.07%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: UiPath's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -27.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): UiPath's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.46%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): UiPath's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.1%, the company may face hurdles in achieving optimal financial returns.
Debt Management: UiPath's debt-to-equity ratio is below the industry average at 0.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 2 Ratings For UiPath

The robotics industry is well-positioned for significant growth due to the increasing adoption of automation and technological advancements. Hence, it could be wise to keep track of leading robotics stocks, Rockwell Automation (ROK), Fanuc Corp (FANUY), and UiPath (PATH). Read more... The robotics industry is poised for significant growth, driven by advancements in AI, automation, and increased adoption across manufacturing, healthcare, and logistics sectors. Therefore, we look into sound robotics stocks, such as Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>), Fanuc Corporation (<a href="https://stocknews.com/stock/FANUY/">FANUY</a>), and UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>), revolutionizing manufacturing.
The U.S. advanced robotics market is expected to grow with a <a href="https://www.globenewswire.com/news-release/2024/11/13/2980393/0/en/Advanced-Robotics-Market-Is-Expected-To-Reach-Revenue-Of-USD-260-9-Bn-By-2033-At-20-8-CAGR-Dimension-Market-Research.html">CAGR of 19.5%</a> by 2033. This expansion is driven by the growing adoption of automation across industries, the need to enhance productivity, and the rising demand for precision in manufacturing and healthcare. Government initiatives promoting technological advancement are boosting robotics research and development.
Additionally, there is a growing focus on the development of advanced AI and machine learning capabilities in robotics, which is expected to drive the growth of this market further. Revenue in robotics is expected to grow at a <a href="https://www.statista.com/outlook/tmo/robotics/united-states">CAGR of 8.7%</a> by 2029.
Considering these conducive trends, let's examine the fundamentals of the three above-mentioned robotics stocks.
Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>)
ROK offers industrial automation and digital transformation solutions internationally. The company operates in three segments, Intelligent Devices; Software &amp; Control; and Lifecycle Services. The company's solutions include hardware and software products and services.
On November 20, ROK and Microsoft expanded their strategic collaboration aimed at revolutionizing industrial transformation. Under the partnership, the companies will provide manufacturing customers with advanced cloud and AI solutions.
The strategic partnership is aimed at delivering advanced cloud and AI solutions, empowering manufacturers with enhanced data insights, operational efficiency, and sustainable growth across the industry.
ROK reported sales of $2.04 billion for the fourth quarter that ended on September 30, 2024, and its <a href="https://www.investopedia.com/terms/g/grossprofit.asp">gross profit</a> was $770.60 million for the period. The company's adjusted income and adjusted EPS came in at $281.90 million and $2.47 for the quarter, respectively.
Analysts expect ROK's revenue and EPS for the fiscal year (ending September 2026) to increase 7.1% and 18.9% year-over-year to $8.79 billion and $11.18, respectively. Further, the company has topped the consensus EPS estimates in three of the trailing four quarters.
ROK's stock has surged 1.6% over the past month and 10.5% over the past six months to close the last trading session at $287.69.
ROK's outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has a B grade for Momentum and Quality. Within the A-rated <a href="https://stocknews.com/category/industrial-machinery/">Industrial - Machinery</a> industry, ROK is ranked #74 among 79 stocks. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
Beyond what is stated above, we've also rated ROK for Growth, Sentiment, Stability, and Value. Get all ROK ratings <a href="https://stocknews.com/stock/ROK/">here</a>.
Fanuc Corporation (<a href="https://stocknews.com/stock/FANUY/">FANUY</a>)
Headquartered in Yamanashi, Japan, FANUY provides factory automation products internationally. The company offers CNC series products, servo motors, lasers, robots, compact machining centers, electric injection molding machines, wire electrical discharge machines, and ultra-precision machines.
FANUY's trailing-12-month EBIT margin of 19.24% is 87.6% higher than the industry average of 10.26%. Its trailing-12-month EBITDA margin of 25.40% is 80.6% higher than the industry average of 14.06%. Also, its 18.05% trailing-12-month levered FCF margin is 170.8% higher than the industry average of 6.67%.
During the fiscal six months, which ended September 30, 2024, FANUY's net sales amounted to ¥387.96 billion ($53.24 billion). The company's operating income and net income for the period amounted to ¥75.59 billion ($10.37 billion) and ¥71.79 billion ($985.20 million), up 13.6% and 10.4% year-over-year, respectively.
Analysts expect FANUY's revenue and EPS for the year quarter (ending March 2024) to increase 71.8% and 119.7% year-over-year to $5.25 billion and $0.10, respectively. Also, the company has topped the consensus revenue estimates in three of the trailing four quarters.
FANUY's shares have plunged 2.4% over the past to close the last trading session at $12.83.
FANUY's fundamentals are reflected in its POWR Ratings. It has a B grade for Momentum, Stability, and Quality. The stock is ranked #58 out of 79 stocks in the Industrial - Machinery industry.
<a href="https://stocknews.com/stock/FANUY/">Click here</a> to access the additional FANUY ratings (Sentiment, Growth, and Value).
UiPath Inc. (<a href="https://stocknews.com/stock/PATH/">PATH</a>)
PATH provides an end-to-end automation platform that offers a range of Robotic Process Automation (RPA) solutions, primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. 
On October 23, PATH announced the transformation of operations for Omega Healthcare, a global leader in revenue cycle management, healthcare, and clinical enablement services, through its AI-powered automation. The partnership could position PATH as a frontrunner in AI-driven automation.
On October 22, PATH announced a strategic partnership with Inflection AI, an enterprise AI company, to introduce the UiPath Platform with the new Inflection for Enterprise solution that would result in achieving higher operational efficiency and effectiveness for enterprises.
PATH could reinforce its commitment to secure and efficient AI-driven solutions through this partnership, positioning itself as a leader in innovative enterprise automation.
For the fiscal third quarter that ended September 30, 2024, PATH's revenue increased 20% year-over-year to $628 million. Its non-GAAP net income stood at $207 million and $0.41 per share, up 24% and 24.2% from the prior-year quarter, respectively.
Street expects PATH's revenue for the fourth quarter (ending January 2025) to increase 5% year-over-year to $425.45 million. Its EPS for the current quarter is expected to be $0.19. Moreover, the company surpassed the consensus revenue and EPS estimates in each of the trailing four quarters, which is impressive.
PATH's stock has soared 3.6% over the past month to close the last trading session at $12.97.
PATH's POWR Ratings reflect its prospects. The stock has an overall rating of B, which equates to a Buy in our proprietary rating system. The stock has a B grade for Growth, Value, and Quality. It is ranked #8 out of 18 in the A-rated <a href="https://stocknews.com/category/software-saas/">Software - SAAS</a> industry.
Beyond what is stated above, we've also rated PATH for Momentum, Stability, and Sentiment. Get all PATH ratings <a href="https://stocknews.com/stock/Path/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
ROK shares were trading at $284.41 per share on Thursday afternoon, down $3.28 (-1.14%). Year-to-date, ROK has declined -6.68%, versus a 25.11% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Nidhi Agarwal</h2> <img src='https:/wp-content/uploads/2023/03/Nidhi-Agarwal_Headshot-3.jpg' style="float:left; padding:5px;width:125px;">Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program.

Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.<a href="https://stocknews.com/authors/?author=nidhi-agarwal">More...</a>The post <a href=https://stocknews.com/news/rok-fanuy-path-3-robotics-stocks-revolutionizing-manufacturing/>3 Robotics Stocks Revolutionizing Manufacturing</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Robotics Stocks Revolutionizing Manufacturing

UiPath: AI Market Leader In An Industry Set To Explode

UiPath Inc Has Been Oversold - Turnaround Likely In CY2025

In a report released today, Raimo Lenschow from Barclays maintained a Hold rating on UiPath (PATH – Research Report), with a price target of $15.00...

Barclays Sticks to Their Hold Rating for UiPath (PATH)

CES And AI: What's The 'Next Big Thing' For 2025?

UiPath: The Generative AI Threat Continues To Take Shape

UiPath Inc. (PATH) 27th Annual Needham Growth Conference (Transcript)

UiPath: The Path Forward Is Getting Smoother

In a report released today, Bryan Bergin from TD Cowen maintained a Hold rating on UiPath (PATH – Research Report), with a price target of $16.00. ...

UiPath Hold Rating: Awaiting Clearer Evidence of Successful Reorganization and Growth Stabilization

Comments

UiPath

UiPath (PATH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga